Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double blind randomized study of metformin versus placebo in the treatment of NASH in obese patients undergoing bariatric surgery
2005-000596-17Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in metabolic dysfunction-associated steatohepatitis (MASH), metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity comparing Metformin with Placebo (2 arms). Primary endpoint: Primary. Started Jul 2005; status: completed.
02
Drugs
metformin
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)metabolic dysfunction-associated steatotic liver disease (MASLD)obesity
Beyond the preview
Go deeper on 2005-000596-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000596-17.